DekaBank Deutsche Girozentrale’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3K Hold
496
﹤0.01% 1098
2025
Q4
$10K Hold
496
﹤0.01% 1376
2025
Q3
$5K Hold
496
﹤0.01% 1382
2025
Q2
$5K Hold
496
﹤0.01% 1391
2025
Q1
$7K Hold
496
﹤0.01% 1392
2024
Q4
$7K Hold
496
﹤0.01% 1413
2024
Q3
$10K Hold
496
﹤0.01% 1419
2024
Q2
$10K Hold
496
﹤0.01% 1440
2024
Q1
$9K Hold
496
﹤0.01% 1427
2023
Q4
$7K Hold
496
﹤0.01% 1471
2023
Q3
$8K Sell
496
-1,076
-68% -$22.4K ﹤0.01% 1482
2023
Q2
$33K Sell
1,572
-1,141
-42% -$24.8K ﹤0.01% 1236
2023
Q1
$63K Buy
2,713
+93
+4% +$2.5K ﹤0.01% 1264
2022
Q4
$73K Sell
2,620
-27,865
-91% -$712K ﹤0.01% 1295
2022
Q3
$712K Sell
30,485
-36,403
-54% -$1.1M ﹤0.01% 966
2022
Q2
$2.27M Buy
+66,888
New +$2.34M 0.01% 694
2022
Q1
Sell
-60,541
Closed -$1.79M 1411
2021
Q4
$1.79M Sell
60,541
-39,580
-40% -$1.29M ﹤0.01% 801
2021
Q3
$3.38M Sell
100,121
-307,218
-75% -$9.83M 0.01% 619
2021
Q2
$12.3M Buy
+407,339
New +$13.4M 0.04% 332

Other funds holding OGN

DekaBank Deutsche Girozentrale's OGN Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale held its Organon & Co (OGN) position steady in Q1 2026 at 496 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

DekaBank Deutsche Girozentrale first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $12.3M in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • DekaBank Deutsche Girozentrale held 496 shares of Organon & Co worth $3K as of Q1 2026.
  • DekaBank Deutsche Girozentrale left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #1098 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • DekaBank Deutsche Girozentrale's Organon & Co position peaked at $12.3M in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.